)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Vivos Therapeutics (VVOS) investor relations material
Vivos Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary19 Nov, 2025
Executive summary
Q3 2025 marked a pivotal inflection point with 76% year-over-year and 78% sequential revenue growth to $6.8M, driven by the first full quarter post-acquisition of Sleep Center of Nevada (SCN) and a strategic shift to direct medical practice affiliations and acquisitions.
SCN contributed $2.2M in sleep testing and $1.3M from new treatment centers, validating the new scalable model and offsetting declines in legacy VIP enrollment revenue.
The company is rapidly expanding capacity, onboarding new providers, and planning further market expansion through acquisitions and alliances.
Management expects continued strong revenue growth, improved margins, and a scalable, replicable model across new markets, but notes substantial doubt about the ability to continue as a going concern without additional financing.
Investments in people and infrastructure at SCN led to higher expenses and net loss, with expectations for eventual reduction in cash burn as operations scale.
Financial highlights
Q3 2025 revenue rose 76% to $6.8M vs. $3.9M in Q3 2024; nine-month revenue reached $13.6M, up from $11.3M in 2024.
Gross profit for Q3 2025 was $3.9M, up from $2.3M; gross margin declined to 58% from 60% year-over-year.
Net loss widened to $5.4M in Q3 2025, or $0.49 per share, reflecting higher costs from the business model shift.
Operating expenses rose 74% to $8.7M in Q3 2025, driven by SCN integration and personnel costs.
Cash and cash equivalents stood at $3.1M, with total liabilities of $23.1M and stockholders' equity at $2.5M as of September 30, 2025.
Outlook and guidance
Management anticipates continued top-line revenue growth as new providers are licensed and credentialed, with a 3–6 month ramp to optimal capacity.
SAMC operations are expected to achieve steady-state contribution margins of 50–60%.
Cash flow break-even is a key goal, expected as more affiliations and acquisitions are completed and operational efficiencies are realized.
Expansion into new markets and specialties, including cardiology and neurology, is underway, with additional affiliations expected in 2026.
There is substantial doubt about the company’s ability to continue as a going concern without additional financing.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Vivos Therapeutics earnings date
Q4 202530 Mar, 2026
Next Vivos Therapeutics earnings date
Q4 202530 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Vivos Therapeutics Inc is a medical technology company focused on the development and commercialization of treatments for sleep-disordered breathing, including obstructive sleep apnea. The company offers oral appliance therapy supported by a network of dental and medical providers. Its approach emphasizes non-invasive, daytime treatments. Vivos Therapeutics Inc is headquartered in Littleton, Colorado, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage